82.40
-2.6(-3.06%)
Currency In EUR
Address
300 Boston Scientific Way
Marlborough, MA 01752-1234
United States of America
Phone
508 683 4000
Sector
Healthcare
Industry
Medical - Devices
Employees
53000
First IPO Date
January 03, 2000
| Name | Title | Pay | Year Born |
| Mr. Michael F. Mahoney | Chairman, President & Chief Executive Officer | 4.77M | 1965 |
| Mr. Jeffrey B. Mirviss M.B.A. | Executive Vice President & President of Peripheral Interventions | 1.34M | 1966 |
| Mr. Arthur Crosswell Butcher | Executive Vice President and Group President of MedSurg & Asia Pacific | 1.52M | 1971 |
| Mr. Joseph M. Fitzgerald | Executive Vice President & Group President of Cardiology | 1.96M | 1964 |
| Mr. Daniel J. Brennan CPA | Executive Vice President & Chief Financial Officer | 2.09M | 1966 |
| Mr. Vance R. Brown J.D. | Senior Vice President, General Counsel & Corporate Secretary | 0 | 1970 |
| Mr. John Bradley Sorenson | Executive Vice President of Global Operations | 0 | 1968 |
| Ms. Jodi Euerle Eddy | Senior Vice President and Chief Information & Digital Officer | 0 | 1973 |
| Mr. Jonathan R. Monson | Senior Vice President of Investor Relations | 0 | N/A |
| Ms. Emily M. Woodworth | Senior Vice President, Global Controller & Chief Accounting Officer | 0 | 1978 |
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
